Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Scryb Inc RYMDF


Primary Symbol: C.SCYB Alternate Symbol(s):  SCYRF

Scryb Inc. is a technology company that provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The Company’s technologies include Cybeats, FRR, and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect high-valued connected devices. The Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac, an AI healthcare company, provides insight into medication behavior. The Company’s platform enables customers across industries to create, enhance and power disruptive solutions.


CSE:SCYB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by chenggongon Jan 08, 2020 1:14am
86 Views
Post# 30529224

Relay receives HemoPalm patent in China

Relay receives HemoPalm patent in ChinaRelay receives HemoPalm patent in China 2020-01-07 16:04 ET - News Release Mr. W. Clark Kent reports UPDATE: RELAY MEDICAL JOINT SPECTROSCOPIC AND BIOSENSOR SYSTEM FOR POINT-OF-CARE TESTING PATENT GRANTED IN CHINA Relay Medical Corp. has provided an update to the Sept. 12 news release regarding the approval for grant of Chinese patent application No. 201580025752.6. The company has been informed that the patent has been officially granted by the Chinese patent authority as patent No. CN106716137B with an expiry date of May 20, 2035. This new patent continues to expand the broad reach of Relay's intellectual property portfolio for its HemoPalm analysis platform in a rapidly advancing market for health care technologies. About Relay Medical Corp.
<< Previous
Bullboard Posts
Next >>